Zobrazeno 1 - 10
of 84
pro vyhledávání: '"Sonpavde GP"'
Publikováno v:
Research and Reports in Urology, Vol Volume 16, Pp 161-176 (2024)
Jonathan Chatzkel,1 Mayer Fishman,2 Brian Ramnaraign,1 Padraic O’Malley,3 Guru P Sonpavde4 1Division of Hematology and Oncology, Department of Medicine, University of Florida, Gainesville, FL, USA; 2University of South Florida, Tampa, FL, USA; 3Dep
Externí odkaz:
https://doaj.org/article/efdf88de76e94c728820ea463707abd0
Autor:
Elizabeth R. Plimack, Salvatore Lo Vullo, Guru Sonpavde, Ulka N. Vaishampayan, Sandy Srinivas, Matthew D. Galsky, Daniele Raggi, Joaquim Bellmunt, Patrizia Giannatempo, Jonathan E. Rosenberg, Aristotle Bamias, Luigi Mariani, Andrea Necchi, Simon J. Crabb, Evan Y. Yu, Guenter Niegisch, Srikala S. Sridhar, Thomas Powles, Christine Theodore, Dominik Berthold
Publikováno v:
Journal of Urology. 200:1207-1214
We evaluated the impact of the number of cycles of platinum based, first line chemotherapy (fewer than 6 cycles vs the conventional 6 cycles or more) on the survival of patients with metastatic urothelial carcinoma.We used the RISC (Retrospective Int
Autor:
Brown JR; Division of Oncology, University Hospitals Seidman Cancer Center, Cleveland, OH, USA; Case Comprehensive Cancer Center, Cleveland, OH, USA. Electronic address: jason.brown3@uhhospitals.org., Sonpavde GP; Department of Hematology/Oncology, AdventHealth Cancer Institute and the University of Central Florida, Orlando, FL, USA., Calaway A; Case Comprehensive Cancer Center, Cleveland, OH, USA; Department of Urology, University Hospitals Seidman Cancer Center, Cleveland, OH, USA., Barata PC; Division of Oncology, University Hospitals Seidman Cancer Center, Cleveland, OH, USA; Case Comprehensive Cancer Center, Cleveland, OH, USA.
Publikováno v:
European urology [Eur Urol] 2024 Oct; Vol. 86 (4), pp. 312-314. Date of Electronic Publication: 2024 Jun 15.
Autor:
Skelton WP 4th; University of Virginia Comprehensive Cancer Center, Department of Oncology, Charlottesville, VA; H. Lee Moffitt Cancer Center and Research Institute, Department of Oncology, Tampa, FL., Masur J; University of Virginia Comprehensive Cancer Center, Department of Oncology, Charlottesville, VA., Thomas J; Dana-Farber Cancer Institute, Department of Oncology, Boston, MA., Fallah P; McGill University, Department of Oncology, Montreal, Quebec, Canada., Jain RK; H. Lee Moffitt Cancer Center and Research Institute, Department of Oncology, Tampa, FL., Ravi P; Dana-Farber Cancer Institute, Department of Oncology, Boston, MA., Mantia C; Dana-Farber Cancer Institute, Department of Oncology, Boston, MA., McGregor BA; Dana-Farber Cancer Institute, Department of Oncology, Boston, MA., Nuzzo PV; Dana-Farber Cancer Institute, Department of Oncology, Boston, MA., Adib E; Dana-Farber Cancer Institute, Department of Oncology, Boston, MA., Zarif TE; Dana-Farber Cancer Institute, Department of Oncology, Boston, MA., Preston MA; Brigham and Women's Hospital, Department of Oncology, Boston, MA., Clinton TN; Brigham and Women's Hospital, Department of Oncology, Boston, MA., Li R; H. Lee Moffitt Cancer Center and Research Institute, Department of Oncology, Tampa, FL., Steele GS; Brigham and Women's Hospital, Department of Oncology, Boston, MA., Kassouf W; McGill University, Department of Oncology, Montreal, Quebec, Canada., Freeman D; Dana-Farber Cancer Institute, Department of Oncology, Boston, MA., Pond GR; McMaster University, Department of Oncology, Hamilton, ON, Canada., Jain RK; Massachusetts General Hospital, Department of Oncology, Boston, MA., Sonpavde GP; Dana-Farber Cancer Institute, Department of Oncology, Boston, MA; AdventHealth Cancer Institute and the University of Central Florida, Department of Oncology, Orlando, FL. Electronic address: Guru.Sonpavde.MD@AdventHealth.com.
Publikováno v:
Clinical genitourinary cancer [Clin Genitourin Cancer] 2024 Oct; Vol. 22 (5), pp. 102143. Date of Electronic Publication: 2024 Jun 24.
Autor:
Roviello G; Department of Health Sciences, University of Florence, Florence, Italy. giandomenico.roviello@unifi.it., Santoni M; Oncology Unit, Macerata Hospital, Macerata, Italy., Sonpavde GP; Dana-Farber Cancer Institute, Boston, MA, USA.; University of Central Florida, Orlando, FL, USA.; AdventHealth Cancer Institute, Orlando, FL, USA., Catalano M; Department of Health Sciences, University of Florence, Florence, Italy.
Publikováno v:
Nature reviews. Urology [Nat Rev Urol] 2024 Oct; Vol. 21 (10), pp. 580-592. Date of Electronic Publication: 2024 May 03.
Autor:
Giudice GC; Medical Oncology Unit, University Hospital of Parma, Parma, Italy.; Department of Medicine and Surgery, University of Parma, Parma, Italy., Sonpavde GP; AdventHealth Cancer Institute and the University of Central Florida, Orlando, Florida, USA.
Publikováno v:
International journal of urology : official journal of the Japanese Urological Association [Int J Urol] 2024 Aug; Vol. 31 (8), pp. 943-944. Date of Electronic Publication: 2024 Jun 02.
Autor:
Lurain K; HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD. Electronic address: kathryn.lurain@nih.gov., Zarif TE; Yale University School of Medicine, New Haven, CT., Ramaswami R; HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD., Nassar AH; Yale University School of Medicine, New Haven, CT., Adib E; Brigham and Women's Hospital, Department of Radiation Oncology, Boston, MA., Abdel-Wahab N; MD Anderson Cancer Center, Houston, TX., Chintapally N; Medstar/Georgetown-Washington Hospital Center, Washington, DC., Drolen CE; University of California Los Angeles Jonsson Comprehensive Cancer Center, Los Angeles, CA., Feldman T; John Theurer Cancer Center, Hackensack, NJ., Haykal T; Department of Medicine, Division of Medical Oncology, Duke University Medical Center, Durham, NC; Ohio State University Comprehensive Cancer Center, Columbus, OH., Nebhan CA; Vanderbilt University Medical Center, Nashville, TN., Kambhampati S; City of Hope Medical Center, Duarte, CA., Li M; Ohio State University Comprehensive Cancer Center, Columbus, OH., Mittra A; Ohio State University Comprehensive Cancer Center, Columbus, OH., Lorentsen M; University of North Carolina, Chapel Hill, NC., Kim C; Medstar Georgetown University Hospital, Washington, DC., Drakaki A; University of California Los Angeles Jonsson Comprehensive Cancer Center, Los Angeles, CA., Morse M; Department of Medicine, Division of Medical Oncology, Duke University Medical Center, Durham, NC., Johnson DB; Vanderbilt University Medical Center, Nashville, TN., Mangla A; University Hospital Seidman Cancer Center, Cleveland, OH., Dittus C; University of North Carolina, Chapel Hill, NC., Ravi P; Dana-Farber Cancer Institute, Boston, MA., Baiocchi RA; Ohio State University Comprehensive Cancer Center, Columbus, OH., Chiao EY; MD Anderson Cancer Center, Houston, TX., Rubinstein PG; John Stroger Cook County Hospital, Chicago, IL., Yellapragada SV; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine & Michael E. DeBakey VA Medical Center, Houston, TX., LaCasce AS; Dana-Farber Cancer Institute, Boston, MA., Sonpavde GP; Dana-Farber Cancer Institute, Boston, MA., Naqash AR; Stephenson Cancer Center, University of Oklahoma, Oklahoma City, OK., Herrera AF; City of Hope Medical Center, Duarte, CA.
Publikováno v:
Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2024 Aug; Vol. 24 (8), pp. 523-530. Date of Electronic Publication: 2024 Apr 05.
Autor:
Giudice GC; Medical Oncology Unit, University Hospital of Parma, Parma, Italy.; Department of Medicine and Surgery, University of Parma, Parma, Italy., Sonpavde GP; AdventHealth Cancer Institute, University of Central Florida, Orlando, FL, USA.
Publikováno v:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2379086. Date of Electronic Publication: 2024 Jul 23.
Autor:
O'Connell KA; Brigham & Women's/Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Department of Dermatology, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Thomas JL; Division of Dermatology, Memorial Sloan Kettering Cancer Center, New York City, New York, USA.; Weill Cornell Medical College, New York City, New York, USA., Murad F; Brigham & Women's/Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA., Zhou G; Center for Clinical Investigation, Brigham and Women's Hospital, Boston, Massachusetts, USA., Sonpavde GP; AdventHealth Cancer Institute, Orlando, Florida, USA., Mossanen M; Division of Urology, Brigham and Women's Hospital and Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA., Clinton TN; Division of Urology, Brigham and Women's Hospital and Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA., Ji-Xu A; Department of Dermatology, University of California, Davis, School of Medicine, Sacramento, California, USA., Spiess PE; Moffitt Cancer Center, Tampa, Florida, USA., Rossi AM; Division of Dermatology, Memorial Sloan Kettering Cancer Center, New York City, New York, USA.; Weill Cornell Medical College, New York City, New York, USA., Schmults CD; Brigham & Women's/Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
Publikováno v:
Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2024 Jun 06. Date of Electronic Publication: 2024 Jun 06.
Autor:
Rosenberg JE; Memorial Sloan Kettering Cancer Center, New York City, NY, USA. Electronic address: rosenbj1@mskcc.org., Mamtani R; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Sonpavde GP; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Loriot Y; Gustave Roussy, Université Paris-Saclay, Villejuif, France., Duran I; Hospital Universitario Marques de Valdecilla, IDIVAL, Santander, Spain., Lee JL; Asan Medical Center and University of Ulsan College of Medicine, Seoul, South Korea., Matsubara N; National Cancer Center Hospital East, Chiba, Japan., Vulsteke C; Center for Oncological Research, University of Antwerp, Integrated Cancer Center Ghent, Ghent, Belgium., Castellano D; Hospital Universitario 12 de Octubre, Madrid, Spain., Sridhar SS; Princess Margaret Cancer Center, Toronto, Canada., Pappot H; Region Hovedstaden, Hillerød, Denmark., Gurney H; Macquarie University, Sydney, Australia., Bedke J; Faculty of Medicine, Eberhard Karls University Tübingen, Tübingen, Germany., van der Heijden MS; Netherlands Cancer Institute, Amsterdam, The Netherlands., Galli L; Azienda Ospedaliero-Universitaria Pisana Spedali Riuniti S. Chiara, Pisa, Italy., Keam B; Seoul National University Hospital, Seoul, South Korea., Masumori N; Sapporo Medical University, Sapporo, Japan., Meran J; Internal Medicine 2, Krankenhaus der Barmherzigen Brüder Wien, Vienna, Austria., O'Donnell PH; University of Chicago, Chicago, IL, USA., Park SH; Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, South Korea., Grande E; MD Anderson Cancer Center Madrid, Madrid, Spain., Sengeløv L; Herlev Gentofte Hospital, Herlev, Denmark., Uemura H; Yokohama City University Medical Center, Yokohama, Japan., Skaltsa K; IQVIA, Barcelona, Spain., Campbell M; Seagen, Bothell, WA, USA., Matsangou M; Astellas Pharma, Northbrook, IL, USA., Wu C; Astellas Pharma, Northbrook, IL, USA., Hepp Z; Seagen, Bothell, WA, USA., McKay C; Astellas Pharma, Northbrook, IL, USA., Powles T; Barts Cancer Centre, Queen Mary University of London, London, UK., Petrylak DP; Smilow Cancer Center, Yale School of Medicine, New Haven, CT, USA.
Publikováno v:
European urology [Eur Urol] 2024 Jun; Vol. 85 (6), pp. 574-585. Date of Electronic Publication: 2024 Feb 28.